Recomendados
Más contenido relacionado
Destacado
Último
Último (20)
Peripheral Neuropathic Pain Pipeline Review H1 2015
- 1. Browse more Reports on Peripheral Neuropathic Pain therapeutics at http://www.rnrmarketresearch.com/peripheral-neuropathic-pain-pipeline-review-h1-2015-market-report.html Peripheral Neuropathic Pain - Pipeline Review, H1 2015 By RnRMarketResearch © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Publisher Name : Global Markets Direct Date: 20-May-2015 No. of pages: 64 Single User License: US $2000
- 2. The Peripheral Neuropathic Pain - Pipeline Review, H1 2015 report gives exhaustive data on the restorative advancement for Peripheral Neuropathic Pain, complete with relative investigation at different stages, therapeutics appraisal by medication target, system of activity (MoA), course of organization (RoA) and atom sort, alongside most recent upgrades, and included news and press discharges. It additionally surveys key players included in the restorative improvement for Peripheral Neuropathic Pain and extraordinary components on late-stage and ceased ventures. Peripheral Neuropathic Pain - Pipeline Review, H1 2015 © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
- 3. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Peripheral Neuropathic Pain - Pipeline Review, H1 2015 Companies Discussed/Mantioned in this Research : AnaBios Corporation, Astellas Pharma Inc., Eli Lilly and Company, GW Pharmaceuticals plc, Nektar Therapeutics, Pfizer Inc., Phosphagenics Limited and Sunovion Pharmaceuticals Inc. Drugs Profile Discussed in this Research : ASP-8477, DSP-2230, duloxetine hydrochloride DR, ECL-1, ketoprofen, nabiximols, NKTR-171, oxycodone ER, pregabalin, Small Molecule 1 for Peripheral Neuropathic Pain and Small Molecule 2 for Peripheral Neuropathic Pain.
- 4. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Scope For Peripheral Neuropathic Pain • The report provides a snapshot of the global therapeutic landscape of Peripheral Neuropathic Pain • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Peripheral Neuropathic Pain and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • Coverage of the Peripheral Neuropathic Pain pipeline on the basis of target, MoA, route of administration and molecule type Peripheral Neuropathic Pain - Pipeline Review, H1 2015
- 5. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Peripheral Neuropathic Pain • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Peripheral Neuropathic Pain - Pipeline Review, H1 2015
- 6. For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Peripheral Neuropathic Pain - Pipeline Review, H1 2015